BRCA


From the Personal to the Population


The Seventh International Symposium on Hereditary Breast and Ovarian Cancer

May 8 - 11, 2018

Centre Mont-Royal, Montréal, Québec, Canada
Deadlines for Abstract Submission
Oral Presentations: December 8, 2017
Posters: January 19, 2018


JOIN WITH

Colleagues, clinicians and researchers from over 25 countries – for the seventh edition of this event which has come to be recognized as one of the leading international scientific conferences on hereditary cancer.

EXPERIENCE

Eureka moments, stimulating exchanges and valuable networking opportunities with colleagues from across North America and abroad.

DISCOVER

Practical insights to increase your understanding of the issues and to learn about new developments in BRCA 1/2 research and clinical care options.



Inspiring Plenaries

Jennifer Blake, MD
The Society of Obstetricians and Gynaecologists of Canada, Ottawa, ON, Canada
Mary-Claire King, PhD
Medical Genetics and Genome Sciences, University of Washington School of Medicine, Seattle, WA, USA



Bartha Maria Knoppers, PhD
Centre of Genomics and Policy, McGill University, Montréal, QC, Canada
Jorge Reis-Filho, MD, PhD
Memorial Sloan-Kettering Cancer Center, New York, NY USA



Mark Robson, MD
Memorial Sloan-Kettering Cancer Center, New York, NY, USA
Sohrab Shah, PhD
University of British Columbia and BC Cancer Agency, Vancouver, BC, Canada



Dominique Stoppa-Lyonnet, PhD
Institut Curie, Paris, France
Laura van’t Veer, PhD
UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA



What's been said...

‘This is such a wonderful way to learn! ’

‘Incredible knowledge sharing. ’

‘Impressive speaker line-up, they truly are key thought leaders in the field.’

‘The level of research and researchers was impressive.’

‘I appreciated the mix of basic science, clinical application & psychosocial lectures. ’

‘Very stimulating to have so many international attendees. Interesting to see differences in practice & approaches to genetic testing. ’

‘Interdisciplinary attendance, really interesting to have bench to bedside represented.’

‘Format was stellar - plenty of time for learning, questions, debate, rest.’

‘Spectacular conference! I can't think of anything else to say!!’

‘Honestly one of the best conferences I've ever been to!!’

‘Near perfect! ’

‘I am a convert; will attend again. ’

‘Well worth the trip & time out of clinic.’

WHO SHOULD ATTEND
Primary care physicians, specialist physicians, laboratory researchers, nurses and genetic counsellors
who are interested in furthering their knowledge in the field of hereditary breast and ovarian cancer.
11 FULL SESSIONS
  • BRCA biology and gene variants
  • New challenges in Genetic Counselling
  • Prevention of HBOC
  • DNA Repair in the clinic: origins, diagnosis and outcomes
  • Plus many more...
Plus...
Full-Day Conference for the General Public
Proffered Papers selected from abstracts
Poster Sessions
And much, much more...
Make Connections

Join with more than 600 colleagues and experts from North America, Europe and beyond

Mix and mingle with newfound colleagues and old friends.